HR 3749 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
To direct the Secretary of Health and Human Services to award grants for research, investigation, and awareness of the effect of personal care products containing endocrine-disrupting chemicals on the female reproductive system, and for other purposes.
Summary
This bill directs the Department of Health and Human Services to award grants for research on the effects of endocrine-disrupting chemicals (chemicals that interfere with hormones) in personal care products on female reproductive health. The bill also provides grants to states to investigate these impacts and develop public awareness campaigns about safer personal care product alternatives. HHS must report every five years on research findings, safe and harmful products, and strategies to expand FDA regulatory authority over these chemical ingredients. The program is designed to address disparities in access to safe personal care products.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
3 cosponsors
Actions (2)
- Jun 5, 2025 Referred to the House Committee on Energy and Commerce. · house
- Jun 5, 2025 Introduced in House
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE HOUSE OF REPRESENTATIVES
June 5, 2025
Ms. Brown (for herself, Mrs. McIver, Mr. Johnson of Georgia, and Ms. Pressley) introduced the following bill; which was referred to the Committee on Energy and Commerce
A BILL
To direct the Secretary of Health and Human Services to award grants for research, investigation, and awareness of the effect of personal care products containing endocrine-disrupting chemicals on the female reproductive system, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Health and Endocrine Research on personal care products for women Act” or the “HER Act”.
SEC. 2. GRANTS FOR RESEARCH, INVESTIGATION, AND AWARENESS REGARDING ENDOCRINE-DISRUPTING CHEMICALS IN PERSONAL CARE PRODUCTS.
(a) Research Grants.—
(1) In general.—The Secretary of Health and Human Services, acting through the Director of the National Institute of Environmental Health Sciences, shall award grants for research on the impact of personal care products containing endocrine-disrupting chemicals on the female reproductive system and related reproductive toxicity concerns.
(2) Reports.—Not later than 5 years after the date of enactment of this Act, and every 5 years thereafter, the Secretary shall submit to the Congress, and make publicly available on the appropriate website of the Department of Health and Human Services, a report based on the results of the research under paragraph (1). Such report shall—
(A) outline research developments and findings related to disparities in access to safe non-endocrine- disrupting personal care products;
(B) list safe and harmful personal care products, as determined by the Secretary; and
(C) include evidence-based or evidence-informed legislative or administrative strategies to increase the Food and Drug Administration’s domain to regulate personal care product ingredients that are endocrine- disrupting chemicals that harm women’s reproductive health.
(b) State Grants for Investigation and Awareness.—
(1) In general.—The Secretary shall award grants to States for carrying out—
(A) programs to investigate the impact of personal care products containing endocrine-disrupting chemicals on women’s reproductive health; and
(B) programs to develop and implement public awareness and education campaigns about the use of alternative personal care products that are less harmful to human health.
(2) Reports.—Not later than 5 years after the initial awarding of grants under paragraph (1), and every 5 years thereafter, the Secretary shall submit to the Congress, and make publicly available on the appropriate website of the Department of Health and Human Services, a report summarizing the findings and results of the programs and activities funded through the grants under paragraph (1).
(c) Definitions.—In this section:
(1) Endocrine-disrupting chemical.—The term “endocrine- disrupting chemical” means a chemical that mimics, blocks, or interferes with the body’s hormones.
(2) Personal care product.—The term “personal care product” means a product that—
(A) is a cosmetic (as defined in section 201 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321)); and
(B) is intended to support the hygiene, grooming, or other personal care of the human body.
(3) Secretary.—The term “Secretary” means the Secretary of Health and Human Services.
(4) State.—The term “State” means—
(A) each of the several States, the District of Columbia, and the territories of the United States; and
(B) an Indian Tribe or Tribal organization (as such terms are defined in section 4 of the Indian Self- Determination and Education Assistance Act (25 U.S.C. 5304)). <all>
Comments